Ready Screen

 

A new concept in preclinical contract research

As a preclinical CRO, we are concerned about the problems and requirements of our customers working in drug discovery. Outsourcing is becoming increasingly convenient for Pharma companies and the need for fast, low cost and reliable services is more pressing than ever.

Testing drug candidates in vivo may be part of the screening strategy. In order to provide a solution for drug screening, Vivotecnia has released a new set of services called Ready Screen, a contract research service specialized in drug discovery.

Ready Screen meets the needs of drug discovery customers through standardization and automatization of the procedures involved in study production, from protocol design to reporting. This allows us to reduce delays to the minimum and increase reliability of results while lowering the costs.

The Ready Screen set is composed of three modules that will help you swiftly resolve the in vivo pharmacokinetic and toxicological profiles of your drug candidate. You can find more information downloading the following technical data sheets:

PK Ready Screen (PDF)

Tox Ready Screen (PDF)

MTD Ready Screen (PDF)